CIP
MED icon

Chartwell Investment Partners’s Medifast MED Stock Holding History

Chartwell Investment Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,534
Closed -$4.55M – 461
2018
Q3 		$4.55M Buy
+20,534
New +$4.16M 0.13% 228

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chartwell Investment Partners's MED Position: Q4 2018 in Review

Chartwell Investment Partners sold out of Medifast (MED) in Q4 2018, closing a stake of 20,534 shares — an estimated $4.55M sold.

Chartwell Investment Partners first reported a position in MED in Q3 2018 and held it in 1 quarter. The position peaked at $4.55M in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

  • Chartwell Investment Partners reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
  • Chartwell Investment Partners sold 20,534 Medifast shares in Q4 2018, an estimated $4.55M.
  • Chartwell Investment Partners first reported a position in Medifast in Q3 2018 and held it in 1 quarter.
  • Chartwell Investment Partners's Medifast position peaked at $4.55M in Q3 2018.
  • 247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Chartwell Investment Partners's 13F filing for Q4 2018, filed 1 Feb 2019.